$63.45
00.00%
Pre-Market: 4:33 PM EDT
Comments
Loading...
Biomarin Pharmaceutical (NASDAQ:BMRN) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Biomarin Pharmaceutical (BMRN)?
The most recent guidance for Biomarin Pharmaceutical (BMRN) was reported on October 29, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $3.25 to $3.35, compared to the estimated EPS of $2.07. Additionally, Biomarin Pharmaceutical forecasted revenue between $2.79B and $2.83B for the quarter.
Browse guidance and forecast on all stocks.